Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/Net Sales

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EV/Net Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Net Sales(x) 6.198.828.92-0.030.06

What is the latest EV/Net Sales ratio of MANKIND PHARMA ?

The latest EV/Net Sales ratio of MANKIND PHARMA is 6.19 based on Mar2026 Consolidated results.
Year EV/Net Sales
Mar20266.19
Mar20258.82
Mar20248.92
Mar2023-0.03
Mar20220.06

How is EV/Net Sales of MANKIND PHARMA Trending?

Years EV/Net Sales % Change
Mar2026 6.19
-29.82
Mar2025 8.82
-1.12
Mar2024 8.92
Positive
Mar2023 -0.03
Negative
Mar2022 0.06 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/Net Sales ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹93,957.5 Cr -5.2% 1.2% -4.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.1% -5% 5.4% Stock Analytics
DIVIS LABORATORIES ₹244,762.0 Cr -1.7% 0.2% 39.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,448.0 Cr -2.5% -5.5% 30.2% Stock Analytics
CIPLA ₹107,043.0 Cr 0.9% -2.6% -14.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,820.0 Cr 0.1% 7.6% -3.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-5.2%

1.2%

-4.2%

SENSEX

3.1%

1%

-9.1%


You may also like the below Video Courses